Sarissa Capital Management LP
Q2 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
7
- Value ($000)
$154,390
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001577524
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INVA INNOVIVA INC | COM | 45781M101 | $56.57M | 37 % | 2,816,022 | ||
NBIX NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $38.10M | 25 % | 303,151 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111404 | $20.15M | 13 % | 1,242,527 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $19.44M | 13 % | 588,357 | ||
IRWD IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | $11.42M | 7 % | 15,919,435 | ||
LNTH LANTHEUS HLDGS INC | COM | 516544103 | $7.88M | 5 % | 96,251 | ||
VOR VOR BIOPHARMA INC | COM | 929033108 | $822.99K | 1 % | 508,016 |
Rows Per Page
10
- 10
- 50
- 100